LONGMONT, Colo. — Building on over ten years of experience in the cell culture and isolation of cell products, KromaTiD is excited to announce the launch of a comprehensive suite of Cell and Blood Culture growth, isolation, processing, and quality control services. Focused on the cell types most important for gene and cell therapy and oncology […]
SOUTH SAN FRANCISCO, Calif.–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today released its inaugural environmental social and governance (ESG) report highlighting Twist’s approach to sustainability, social responsibility and commitment to ethics. The full report is available to view at https://www.twistbioscience.com/company/esg. […]
VIENNA — Ribbon Biolabs, the DNA synthesis company, today announced the successful close of EUR 18 million in its Series A funding round from a consortium of European and US investors led by Hadean Ventures and with participation from Lansdowne Partners, Helicase Venture as well as several undisclosed investors. Existing investors IST cube and tecnet equity […]
HERCULES, Calif. – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today introduced four inhibitory antibodies that are highly specific to pertuzumab (Perjeta). These ready-made antibodies inhibit the binding of the drug to its target, human epidermal growth factor 2 (HER2), enabling researchers to develop […]
Brings Significant Operational Experience in Building Therapeutic Drug Development Businesses TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced it has appointed biopharmaceutical industry veteran Christopher Kiritsy to its Board of Directors. Currently the Managing Member of Precision Kapital, LLC, a private […]
MyChem’s nucleotide synthesis methods are highly complementary to Maravai’s TriLink mRNA technologies Increases capabilities serving the high-growth cell and gene therapy market SAN DIEGO — Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced today that it has acquired MyChem, LLC for $240 million in […]
Hamilton Bonaduz AG announces first walk-away automation solution for PacBio’s High Molecular Weight DNA extraction technology BONADUZ, Switzerland — Hamilton Bonaduz AG (“Hamilton”), a leading liquid handling and laboratory automation technology company, announced today that they have collaborated with PacBio. (Nasdaq: PACB), a leading provider of high-quality, long-read sequencing platforms, to offer a walk-away automation solution […]
CINCINNATI — Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that John C. McIlwraith has been elected as Chairman of the Meridian Board of Directors, effective January 26, 2022. Mr. McIlwraith succeeds David C. Phillips, who retired after serving for more than 21 […]
LAUSANNE, Switzerland – Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, today announced that Alice T. Feng will join the Lunaphore leadership team as Chief Financial Officer, effective January 31, 2022. Ms. Feng brings over two decades of finance and corporate development leadership experience as well as investment banking expertise, […]
Congenica and the Institute of Applied Biotechnologies Agree to Distribution Deal in Central Europe Cambridge, United Kingdom – Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, today announces a strategic partnership with the Institute of Applied Biotechnologies (IAB) as a distributor for Czech Republic, Slovakia, Hungary and Poland. IAB will distribute Congenica’s CE Marked IVD clinical […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
